# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-034715
Filing Date
2024-08-05
Accepted
2024-08-05 16:02:11
Documents
96
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | mrk-20240630.htm iXBRL | 10-Q | 2798308
2 | EX-31.1 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CEO | exhibit311-rule13ax14a15dx.htm | EX-31.1 | 8391
3 | EX-31.2 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CFO | exhibit312-rule13ax14a15dx.htm | EX-31.2 | 8237
4 | EX-32.1 SECTION 1350 CERTIFICATION OF CEO | exhibit321-section1350cert.htm | EX-32.1 | 3869
5 | EX-32.2 SECTION 1350 CERTIFICATION OF CFO | exhibit322-section1350cert.htm | EX-32.2 | 3717
| Complete submission text file | 0001628280-24-034715.txt |  | 15040205

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | mrk-20240630.xsd | EX-101.SCH | 70794
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | mrk-20240630_cal.xml | EX-101.CAL | 86187
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | mrk-20240630_def.xml | EX-101.DEF | 467864
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | mrk-20240630_lab.xml | EX-101.LAB | 819805
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | mrk-20240630_pre.xml | EX-101.PRE | 670585
98 | EXTRACTED XBRL INSTANCE DOCUMENT | mrk-20240630_htm.xml | XML | 3603698

Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06571 | Film No.: 241174647
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)